To express the sense of the House of Representatives regarding the Medicare national coverage determination on the treatment of anemia in cancer patients.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Expresses the sense of the House of Representatives that the Centers for Medicare and Medicaid Services should: (1) begin an immediate reconsideration of the final National Coverage Determination on the Use of Erythropoiesis Stimulating Agents in Cancer and Related Neoplastic Conditions; (2) consult with members of the clinical oncology community to determine appropriate revisions to such Determination; and (3) implement appropriate revisions to such Determination as soon as feasible and provide a briefing to Congress in advance of announcing such changes.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H. Res. 681: To express the sense of the House of Representatives regarding the Medicare national coverage determination on the treatment of anemia in cancer patients.. 110th Congress. Open America. https://openamerica.io/bill/110-HRES-681/
"H. Res. 681: To express the sense of the House of Representatives regarding the Medicare national coverage determination on the treatment of anemia in cancer patients.." 110th Congress, 2026, Open America, https://openamerica.io/bill/110-HRES-681/.
H. Res. 681, 110th Cong. (2026), https://openamerica.io/bill/110-HRES-681/.
[H. Res. 681: To express the sense of the House of Representatives regarding the Medicare national coverage determination on the treatment of anemia in cancer patients.](https://openamerica.io/bill/110-HRES-681/)